KARDEGIC Side Effects

6945162-7 | Haematoma, Physical Disability
on Aug 17, 2010 Male patient from FRANCE , 71 years of age, was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, physical disability. Kardegic dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), HEPARINE CHOAY (View Heparine Choay Review and Heparine Choay Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), LASIX (View Lasix Review and Lasix Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ). Patient was hospitalized.

6914410-1 | Chest Pain, Dyspnoea, Mitral Valve Disease, Pulmonary Valve Disease, Tricuspid Valve Disease
Patient was taking Kardegic (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, mitral valve disease, pulmonary valve disease, tricuspid valve disease on Jul 30, 2010 from FRANCE Additional patient health information: Female patient , 48 years of age, . Kardegic dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), IKOREL (View Ikorel Review and Ikorel Label ), ISOMERIDE (View Isomeride Review and Isomeride Label ), MEDIATOR (View Mediator Review and Mediator Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ), CRESTOR (View Crestor Review and Crestor Label ), TARDYFERON /GFR/ (View Tardyferon /gfr/ Review and Tardyferon /gfr/ Label ).

6899870-7 | Haematoma, Haematuria, International Normalised Ratio Increased, Petechiae
Adverse event was reported on Jul 22, 2010 by a Female patient taking Kardegic (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis, hyperthermia and. Location: FRANCE , 88 years of age, After Kardegic was administered, patient had the following side effects: haematoma, haematuria, international normalised ratio increased, petechiae. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), PREVISCAN (View Previscan Review and Previscan Label ), CIFLOX (View Ciflox Review and Ciflox Label ), DIFFU K (View Diffu K Review and Diffu K Label ), COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

6794846-2 | Anaemia, Circulatory Collapse, Muscle Haemorrhage, Overdose, Thrombocytopenia
on Jun 16, 2010 Female patient from FRANCE , 83 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?), pain (What is pain?) and was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, circulatory collapse, muscle haemorrhage, overdose, thrombocytopenia. Kardegic dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), BIPROFENID (View Biprofenid Review and Biprofenid Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), ATARAX (View Atarax Review and Atarax Label ), DURAGESIC 100 (1 Patch All 72 Hours (50 ?mol/hour) ( 8.4 Mg/21 Cm2)= 1df For 72 Hours.) (View Duragesic-100 Review and Duragesic-100 Label ), XANAX (View Xanax Review and Xanax Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CONTRAMAL (View Contramal Review and Contramal Label ).


6772906-X | Anaemia, International Normalised Ratio Increased, Melaena, Rectal Haemorrhage
on Jun 09, 2010 Male patient from FRANCE , 74 years of age, was diagnosed with thrombosis prophylaxis, pain (What is pain?) and was treated with Kardegic (View Usage). Patient had the following side effects: anaemia, international normalised ratio increased, melaena, rectal haemorrhage. Kardegic dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), PREVISCAN (View Previscan Review and Previscan Label ), MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TRIATEC (View Triatec Review and Triatec Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), ODRIK (View Odrik Review and Odrik Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6681307-4 | Anaemia, International Normalised Ratio Increased, Melaena, Rectal Haemorrhage
Patient was taking Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: anaemia, international normalised ratio increased, melaena, rectal haemorrhage on Apr 06, 2010 from FRANCE Additional patient health information: Male patient , 74 years of age, was diagnosed with thrombosis prophylaxis, pain (What is pain?) and. Kardegic dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), PREVISCAN (View Previscan Review and Previscan Label ), MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ODRIK (View Odrik Review and Odrik Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6653516-1 | International Normalised Ratio Increased, Subdural Haematoma
Adverse event was reported on Mar 22, 2010 by a Female patient taking Kardegic (View Usage) (Dosage: ) . Location: FRANCE , 85 years of age, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, subdural haematoma. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), PREVISCAN (View Previscan Review and Previscan Label ).

6646361-4 | Thrombocytopenia
on Mar 11, 2010 Female patient from FRANCE , 89 years of age, was treated with Kardegic (View Usage). Patient had the following side effects: thrombocytopenia. Kardegic dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LASIX (View Lasix Review and Lasix Label ), TRIATEC (View Triatec Review and Triatec Label ), INIPOMP (View Inipomp Review and Inipomp Label ), EFFEXOR (View Effexor Review and Effexor Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6634363-3 | Thrombocytopenia
on Mar 11, 2010 Female patient from FRANCE , 89 years of age, was treated with Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: thrombocytopenia. Kardegic dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LASILIX (View Lasilix Review and Lasilix Label ), TRIATEC (View Triatec Review and Triatec Label ), INIPOMP (View Inipomp Review and Inipomp Label ), EFFEXOR (View Effexor Review and Effexor Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6578323-X | Disseminated Intravascular Coagulation
Patient was taking Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation on Feb 09, 2010 from FRANCE Additional patient health information: Male patient , 77 years of age, was diagnosed with hypercholesterolaemia, cardiac failure and. Kardegic dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), SERESTA (View Seresta Review and Seresta Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TAHOR (View Tahor Review and Tahor Label ), KREDEX (View Kredex Review and Kredex Label ).

6547219-1 | Dry Mouth, Xerophthalmia
Adverse event was reported on Jan 18, 2010 by a Male patient taking Kardegic (View Usage) (Dosage: ) was diagnosed with peripheral arterial occlusive disease and. Location: FRANCE , 59 years of age, Patient had the following side effects: dry mouth, xerophthalmia. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), VIDEX (View Videx Review and Videx Label ), VIREAD (View Viread Review and Viread Label ), SUSTIVA (View Sustiva Review and Sustiva Label ).

6519106-6 | Toxic Epidermal Necrolysis
on Dec 22, 2009 Male patient from FRANCE , 78 years of age, was diagnosed with infection (What is infection?), depression (What is depression?) and was treated with Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: toxic epidermal necrolysis. Kardegic dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), CIFLOX (View Ciflox Review and Ciflox Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6460816-7 | Subarachnoid Haemorrhage, Subdural Haematoma
on Nov 24, 2009 Female patient from FRANCE , 84 years of age, was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: subarachnoid haemorrhage, subdural haematoma. Kardegic dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), PLAVIX (View Plavix Review and Plavix Label ), AMLOR (View Amlor Review and Amlor Label ), IKOREL (View Ikorel Review and Ikorel Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TARDYFERON /GFR/ (View Tardyferon /gfr/ Review and Tardyferon /gfr/ Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ).

6457870-5 | Pruritus, Toxic Skin Eruption
Patient was taking Kardegic (View Usage). Patient had the following side effects: pruritus, toxic skin eruption on Nov 18, 2009 from FRANCE Additional patient health information: Male patient , 80 years of age, was diagnosed with peritoneal dialysis and. Kardegic dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), LASILIX (View Lasilix Review and Lasilix Label ), EXTRANEAL (View Extraneal Review and Extraneal Label ), PREVISCAN (View Previscan Review and Previscan Label ), CALCIDIA (View Calcidia Review and Calcidia Label ), TRIATEC (View Triatec Review and Triatec Label ), AMLOR (View Amlor Review and Amlor Label ), RENAGEL (View Renagel Review and Renagel Label ). Patient was hospitalized.

6438870-8 | Blood Creatinine Increased, Cardiac Failure, Hyperkalaemia, Hypochloraemia, Hyponatraemia, Left Ventricular Dysfunction, Renal Failure
Adverse event was reported on Nov 05, 2009 by a Male patient taking Kardegic (View Usage) (Dosage: ) . Location: FRANCE , 65 years of age, After Kardegic was administered, patient had the following side effects: blood creatinine increased, cardiac failure, hyperkalaemia, hypochloraemia, hyponatraemia, left ventricular dysfunction, renal failure. During the same period patient was treated with COVERSYL 2MG (Daily Dose: 2 Milligram(s), Frequency: Once A Day) (View Coversyl 2mg Review and Coversyl 2mg Label ), TAHOR (View Tahor Review and Tahor Label ), LASILIX (Daily Dose: 500 Milligram(s), Frequency: Once A Day) (View Lasilix Review and Lasilix Label ). Patient was hospitalized.

6317021-4 | Iliac Artery Stenosis
on Jul 16, 2009 Male patient from FRANCE , 58 years of age, was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: iliac artery stenosis. Kardegic dosage: Unk. During the same period patient was treated with PLAVIX (Unk) (View Plavix Review and Plavix Label ).

6232103-3 | Myocardial Infarction
on Jun 09, 2009 Male patient from FRANCE , weighting 209.4 lb, was diagnosed with coronary artery bypass (What is coronary artery bypass?), gastric cancer, hypertension, dyslipidaemia, prophylaxis and was treated with Kardegic (View Usage). Patient had the following side effects: myocardial infarction. Kardegic dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), OMACOR (View Omacor Review and Omacor Label ), CRESTOR (View Crestor Review and Crestor Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LODOZ (View Lodoz Review and Lodoz Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

6195462-6 | Myocardial Infarction
Patient was taking Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: myocardial infarction on May 13, 2009 from FRANCE Additional patient health information: Male patient , weighting 209.4 lb, was diagnosed with coronary artery bypass (What is coronary artery bypass?), gastric cancer, hypertension, dyslipidaemia, prophylaxis and. Kardegic dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), APROVEL (View Aprovel Review and Aprovel Label ), OMACOR (View Omacor Review and Omacor Label ), CRESTOR (View Crestor Review and Crestor Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LODOZ (View Lodoz Review and Lodoz Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ).

6186589-3 | Agranulocytosis, Sepsis
Adverse event was reported on Apr 30, 2009 by a Male patient taking Kardegic (View Usage) (Dosage: ) was diagnosed with pancreatitis and. Location: FRANCE , 86 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, sepsis (What is sepsis?). During the same period patient was treated with CREON (Daily Dose: 3 Dosage Form) (View Creon Review and Creon Label ), FORLAX (Daily Dose: 1 Dosage Form) (View Forlax Review and Forlax Label ), TENORMIN (Daily Dose: 50 Milligram(s)) (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

6141326-3 | Hypotension
on Mar 26, 2009 Male patient from FRANCE , weighting 209.4 lb, was diagnosed with coronary artery bypass (What is coronary artery bypass?), gastric cancer, hypertension, dyslipidaemia, prophylaxis and was treated with Kardegic (View Usage). Patient had the following side effects: hypotension. Kardegic dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), APROVEL (View Aprovel Review and Aprovel Label ), OMACOR (View Omacor Review and Omacor Label ), CRESTOR (View Crestor Review and Crestor Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LODOZ (View Lodoz Review and Lodoz Label ).

6102241-4 | Diarrhoea, Dysphagia, Weight Decreased
on Feb 25, 2009 Male patient from FRANCE , weighting 209.4 lb, was diagnosed with gastric cancer and was treated with Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: diarrhoea, dysphagia, weight decreased. Kardegic dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), APROVEL (View Aprovel Review and Aprovel Label ), OMACOR (View Omacor Review and Omacor Label ), CRESTOR (View Crestor Review and Crestor Label ).

6051982-6 | Gastrointestinal Haemorrhage, Peripheral Ischaemia, Vascular Stenosis
Patient was taking Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, peripheral ischaemia, vascular stenosis on Jan 14, 2009 from FRANCE Additional patient health information: Male patient , weighting 138.9 lb, was diagnosed with myocardial infarction, hypertension, dyslipidaemia, coronary artery disease (What is coronary artery disease?) and. Kardegic dosage: Unk. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), CARDENSIEL (Unk) (View Cardensiel Review and Cardensiel Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), NOVOTILDIEM SR (Unk) (View Novotildiem Sr Review and Novotildiem Sr Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ).

5624184-2 | Anaemia, Dyskinesia, Gastroduodenal Ulcer, Heart Rate Increased, Loss Of Consciousness, Malaise, Melaena, Pallor
Adverse event was reported on Feb 08, 2008 by a Male patient taking Kardegic (View Usage) (Dosage: 75 Mg, Qd) was diagnosed with pain (What is pain?) and. Location: FRANCE , 89 years of age, Patient had the following side effects: anaemia, dyskinesia, gastroduodenal ulcer, heart rate increased, loss of consciousness, malaise, melaena, pallor. During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), HYTACAND (4 Mg, Qd) (View Hytacand Review and Hytacand Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), CERVOXAN (60 Mg, Qd) (View Cervoxan Review and Cervoxan Label ), SPECIAFOLDINE (1 Df, Qd) (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

5567022-9 | Cholestasis, Dermatitis, Eosinophilia
on Dec 10, 2007 Male patient from FRANCE , weighting 198.4 lb, was diagnosed with ill-defined disorder, skin ulcer and was treated with Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: cholestasis, dermatitis, eosinophilia. Kardegic dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), OGAST (View Ogast Review and Ogast Label ), BISEPTINE (View Biseptine Review and Biseptine Label ), PREVISCAN (View Previscan Review and Previscan Label ), DEXERYL (View Dexeryl Review and Dexeryl Label ), AMLOR (View Amlor Review and Amlor Label ), CORVASAL (View Corvasal Review and Corvasal Label ), BURINEX (View Burinex Review and Burinex Label ). Patient was hospitalized.

5545278-6 | Atrial Fibrillation, Gastritis Haemorrhagic, Haemoglobin Decreased, Melaena
on Dec 03, 2007 Female patient from FRANCE , 77 years of age, was diagnosed with depression (What is depression?), osteoarthritis (What is osteoarthritis?) and was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), gastritis haemorrhagic, haemoglobin decreased, melaena. Kardegic dosage: 160 Mg, Qd. During the same period patient was treated with LUDIOMIL (View Ludiomil Review and Ludiomil Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

5475926-0 | Colitis
Patient was taking Kardegic (View Usage). Patient had the following side effects: colitis on Sep 21, 2007 from FRANCE Additional patient health information: Female patient , 75 years of age, weighting 146.2 lb, was diagnosed with osteoporosis (What is osteoporosis?) and. Kardegic dosage: . During the same period patient was treated with INEXIUM (View Inexium Review and Inexium Label ), FORTEO (20 Ug, Daily (1/d)) (View Forteo Review and Forteo Label ), LERCAN (View Lercan Review and Lercan Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

5456350-3 | Anaemia, Chest Pain, Fall, Haemoglobin Decreased, Hypokalaemia, International Normalised Ratio Increased
Adverse event was reported on Sep 13, 2007 by a Male patient taking Kardegic (View Usage) (Dosage: 75 Mg, Qd) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: FRANCE , 77 years of age, After Kardegic was administered, patient had the following side effects: anaemia, chest pain (What is chest pain?), fall (What is fall?), haemoglobin decreased, hypokalaemia, international normalised ratio increased. During the same period patient was treated with ZOCOR (40 Mg, Qd) (View Zocor Review and Zocor Label ), PLAVIX (1 Df, Qd) (View Plavix Review and Plavix Label ), AMLOR (5 Mg, Qd) (View Amlor Review and Amlor Label ), VASTAREL (70 Mg, Qd) (View Vastarel Review and Vastarel Label ), NEXIUM (20 Mg, Qd) (View Nexium Review and Nexium Label ), COTAREG (1 Df, Qd) (View Cotareg Review and Cotareg Label ), PREVISCAN (20 Mg, Qd) (View Previscan Review and Previscan Label ). Patient was hospitalized.

5290526-3 | Agranulocytosis, Angina Unstable
on Mar 30, 2007 Male patient from FRANCE , 53 years of age, was diagnosed with ill-defined disorder and was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, angina unstable. Kardegic dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), TAHOR (View Tahor Review and Tahor Label ), PLAVIX (View Plavix Review and Plavix Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

5274176-0 | Stent Occlusion
on Mar 13, 2007 Female patient from FRANCE , 65 years of age, was diagnosed with stent placement, hypertension, dyslipidaemia and was treated with Kardegic (View Usage). Patient had the following side effects: stent occlusion. Kardegic dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), LASIX (80 Mg) (View Lasix Review and Lasix Label ), CRESTOR (View Crestor Review and Crestor Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PLAVIX (View Plavix Review and Plavix Label ).

5274173-5 | Stent Occlusion
Patient was taking Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: stent occlusion on Mar 13, 2007 from FRANCE Additional patient health information: Male patient , 81 years of age, was diagnosed with myocardial infarction and. Kardegic dosage: Unk. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

5247859-6 | Blood Thyroid Stimulating Hormone Decreased, Cardiomyopathy, Dysphagia, Gastrointestinal Tube Insertion, Haemangioma, Hyperthyroidism, Iodine Uptake Increased, Thyroid Neoplasm
Adverse event was reported on Feb 19, 2007 by a Male patient taking Kardegic (View Usage) (Dosage: 1 Df, Qd) was diagnosed with cardiomyopathy (What is cardiomyopathy?), brain neoplasm, hypertension and. Location: FRANCE , 83 years of age, Patient experienced the following unwanted or unexpected effects: blood thyroid stimulating hormone decreased, cardiomyopathy (What is cardiomyopathy?), dysphagia, gastrointestinal tube insertion, haemangioma, hyperthyroidism, iodine uptake increased, thyroid neoplasm. During the same period patient was treated with OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), TEMGESIC (0.2 Mg, Qd) (View Temgesic Review and Temgesic Label ), MICARDIS (1 Df, Qd) (View Micardis Review and Micardis Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), NITRODERM (1 Df, Qd) (View Nitroderm Review and Nitroderm Label ), NEO MERCAZOLE TAB (View Neo-mercazole Tab Review and Neo-mercazole Tab Label ). Patient was hospitalized.

5243525-1 | Blood Thyroid Stimulating Hormone Decreased, Cardiomyopathy, Dysphagia, Gastrointestinal Tube Insertion, Haemangioma, Hyperthyroidism, Iodine Uptake Increased, Thyroid Neoplasm
on Feb 19, 2007 Male patient from FRANCE , 83 years of age, was diagnosed with cardiomyopathy (What is cardiomyopathy?), brain neoplasm, hypertension and was treated with Kardegic (View Usage). Patient had the following side effects: blood thyroid stimulating hormone decreased, cardiomyopathy (What is cardiomyopathy?), dysphagia, gastrointestinal tube insertion, haemangioma, hyperthyroidism, iodine uptake increased, thyroid neoplasm. Kardegic dosage: 1 Df, Qd. During the same period patient was treated with OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), TEMGESIC (0.2 Mg, Qd) (View Temgesic Review and Temgesic Label ), MICARDIS (1 Df, Qd) (View Micardis Review and Micardis Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), NITRODERM (1 Df, Qd) (View Nitroderm Review and Nitroderm Label ), NEO MERCAZOLE TAB (View Neo-mercazole Tab Review and Neo-mercazole Tab Label ). Patient was hospitalized.

4973476-9 | Anaemia, Neutropenia
on Apr 05, 2006 Male patient from FRANCE , 78 years of age, was treated with Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: anaemia, neutropenia. Kardegic dosage: Unk. During the same period patient was treated with XATRAL (View Xatral Review and Xatral Label ), MOPRAL (Unk) (View Mopral Review and Mopral Label ), COVERSYL (Unk) (View Coversyl Review and Coversyl Label ), EUPRESSYL (60 Mg) (View Eupressyl Review and Eupressyl Label ), AVANDAMET (Unk) (View Avandamet Review and Avandamet Label ), ZANIDIP (Unk) (View Zanidip Review and Zanidip Label ), DIFFU K (Unk) (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

4895055-4 | Cardiac Arrest, Cerebrovascular Accident, Meningitis, Respiratory Arrest
Patient was taking Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), cerebrovascular accident, meningitis (What is meningitis?), respiratory arrest on Jan 11, 2006 from FRANCE Additional patient health information: Female patient , 71 years of age, . Kardegic dosage: 75 Mg, Qd. During the same period patient was treated with KENZEN (8 Mg/day) (View Kenzen Review and Kenzen Label ), CELEBREX (1 Df, Qd) (View Celebrex Review and Celebrex Label ), CELECTOL (200 Mg, Qd) (View Celectol Review and Celectol Label ), AMLOR (5 Mg, Qd) (View Amlor Review and Amlor Label ), NITRODERM (1 Df, Qd) (View Nitroderm Review and Nitroderm Label ). Patient was hospitalized.

4890904-8 | Cardiac Arrest, Cerebrovascular Accident, Meningitis, Respiratory Arrest
Adverse event was reported on Jan 11, 2006 by a Female patient taking Kardegic (View Usage) (Dosage: 75 Mg, Qd) . Location: FRANCE , 71 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cerebrovascular accident, meningitis (What is meningitis?), respiratory arrest. During the same period patient was treated with KENZEN (8 Mg/day) (View Kenzen Review and Kenzen Label ), CELEBREX (1 Df, Qd) (View Celebrex Review and Celebrex Label ), CELECTOL (200 Mg, Qd) (View Celectol Review and Celectol Label ), AMLOR (5 Mg, Qd) (View Amlor Review and Amlor Label ), NITRODERM (1 Df, Qd) (View Nitroderm Review and Nitroderm Label ). Patient was hospitalized.

4873254-5 | Dizziness, Fall, Loss Of Consciousness, Malaise, Vision Blurred
on Dec 30, 2005 Male patient from FRANCE , 64 years of age, weighting 92.59 lb, was treated with Kardegic (View Usage). After Kardegic was administered, patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), loss of consciousness, malaise, vision blurred. Kardegic dosage: . During the same period patient was treated with TRIATEC (2.5 Mg, Qd) (View Triatec Review and Triatec Label ), ESIDRIX (25 Mg, Qd) (View Esidrix Review and Esidrix Label ), NORSET (45 Mg/day) (View Norset Review and Norset Label ), VALIUM (10 Mg, Qd) (View Valium Review and Valium Label ), XATRAL SLOW RELEASE (10 Mg, Qd) (View Xatral - Slow Release Review and Xatral - Slow Release Label ), GARDENAL (100 Mg, Tid) (View Gardenal Review and Gardenal Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), VITAMIN B1 AND B6 (View Vitamin B1 And B6 Review and Vitamin B1 And B6 Label ). Patient was hospitalized.

4748223-6 | Blood Creatinine Increased, Bone Marrow Transplant, Dialysis, Nephritis Interstitial, Nephroangiosclerosis, Nephropathy Toxic, Proteinuria, Renal Failure Acute
on Jan 14, 2005 Male patient from FRANCE , 60 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, bone marrow transplant (What is bone marrow transplant?), dialysis (What is dialysis?), nephritis interstitial, nephroangiosclerosis, nephropathy toxic, proteinuria, renal failure acute. Kardegic dosage: 75 Mg, Qd. During the same period patient was treated with THALIDOMIDE (Unk, Unk) (View Thalidomide Review and Thalidomide Label ), ZOCOR (20 Mg, Qd) (View Zocor Review and Zocor Label ), FLUDEX (Unk, Unk) (View Fludex Review and Fludex Label ), AMLODIPINE BESYLATE (10 Mg, Qd) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), NEORECORMON ^ROCHE^ (10000 Iu, Qw) (View Neorecormon ^roche^ Review and Neorecormon ^roche^ Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ). Patient was hospitalized.

4653129-7 | Disseminated Intravascular Coagulation, Hypothyroidism, Vasculitis Necrotising
Patient was taking Kardegic (View Usage). Patient had the following side effects: disseminated intravascular coagulation, hypothyroidism, vasculitis necrotising on Apr 28, 2005 from Additional patient health information: Female patient , 68 years of age, was diagnosed with ill-defined disorder and. Kardegic dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), LASILIX (View Lasilix Review and Lasilix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

4621843-5 | Epistaxis, Thrombocytopenic Purpura
Adverse event was reported on Mar 17, 2005 by a Male patient taking Kardegic (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?) and. Location: , 82 years of age, After Kardegic was administered, patient had the following side effects: epistaxis, thrombocytopenic purpura. During the same period patient was treated with ZOLPIDEM TARTRATE (Unk) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), NITROGLYCERIN (Unk) (View Nitroglycerin Review and Nitroglycerin Label ), AMOXICILLIN (Unk) (View Amoxicillin Review and Amoxicillin Label ), ZOCOR (Unk) (View Zocor Review and Zocor Label ), PRAXINOR (View Praxinor Review and Praxinor Label ), TRUSOPT (Unk) (View Trusopt Review and Trusopt Label ), PHOSPHALUGEL (Unk) (View Phosphalugel Review and Phosphalugel Label ), TRIFLUCAN (Unk) (View Triflucan Review and Triflucan Label ). Patient was hospitalized.

4596674-5 | Anaemia, Colitis Ischaemic, Ecchymosis, Rectal Haemorrhage
on Feb 18, 2005 Female patient from , 79 years of age, was diagnosed with acute myocardial infarction and was treated with Kardegic (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, colitis ischaemic, ecchymosis, rectal haemorrhage. Kardegic dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), NOCTRAN (View Noctran Review and Noctran Label ), CORVASAL (View Corvasal Review and Corvasal Label ), DEPAKOTE (View Depakote Review and Depakote Label ), ZESTRIL (View Zestril Review and Zestril Label ). Patient was hospitalized.

4587912-3 | Blood Creatinine Increased, Nephritis Interstitial, Proteinuria, Renal Failure Acute
on Jan 14, 2005 Male patient from , 60 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Kardegic (View Usage). Patient had the following side effects: blood creatinine increased, nephritis interstitial, proteinuria, renal failure acute. Kardegic dosage: 75 Mg, Qd. During the same period patient was treated with THALIDOMIDE (Unk, Unk) (View Thalidomide Review and Thalidomide Label ), ZOCOR (20 Mg, Qd) (View Zocor Review and Zocor Label ), FLUDEX (View Fludex Review and Fludex Label ), AMLOR (10 Mg, Qd) (View Amlor Review and Amlor Label ), NEORECORMON ^ROCHE^ (10000 Iu, Qw) (View Neorecormon ^roche^ Review and Neorecormon ^roche^ Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ). Patient was hospitalized.